Cookies

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.


Durham Research Online
You are in:

The diagnostic accuracy and utility of a B-natriuretic peptide test in a community population of patients with suspected heart failure.

Fuat, A. and Hungin, A. and Murphy, J. J. and Curry, J. and Mehrzad, A. A. and Hetherington, A. and Johnston, J. I. and Smellie, W. S. and Duffy, V. and Cawlwy, P. (2006) 'The diagnostic accuracy and utility of a B-natriuretic peptide test in a community population of patients with suspected heart failure.', British journal of general practice., 56 (526). pp. 327-333.

Abstract

Background: National guidelines suggest the use of natriuretic peptides in suspected heart failure but there have been no studies comparing assays in primary care. Aim: To test and compare the diagnostic accuracy and utility of B-type natriuretic peptide (BNP) and N-terminal B-type natriuretic peptide (NT proBNP) in diagnosing heart failure due to left ventricular systolic dysfunction in patients with suspected heart failure referred by GPs to one-stop diagnostic clinics. Design of study: Community cohort, prospective, diagnostic accuracy study. Setting: One-stop diagnostic clinics in Darlington Memorial and Bishop Auckland General Hospitals and general practices in South Durham. Subjects: Two hundred and ninety-seven consecutive patients with symptoms and signs suggestive of heart failure referred from general practice. Method: The study measured sensitivity, specificity, positive and negative predictive values (PPV, NPV), and area under receiver operating characteristic curve for BNP (near patient assay) and NT proBNP (laboratory assay) in diagnosis of heart failure due to left ventricular systolic dysfunction. The NPV of both assays was determined as a potential method of reducing the number of referrals for echocardiography. Results: One hundred and fourteen of the 297 patients had left ventricular systolic dysfunction (38%). At the manufacturer's recommended cut-off of 100 pg/ml BNP gave a NPV of 82%. BNP performed better at a cut-off of 40 pg/ml with a NPV of 88%. At a cut-off of 150 pg/ml, NT proBNP gave a NPV of 92%. Using cut-offs of 40 pg/ml and 150 pg/ml for BNP and NT pro-BNP, respectively, could have prevented 24% and 25% of referrals to the clinic, respectively. Conclusions: In this setting, NT pro-BNP performed marginally better than BNP, and would be easier to use practically in primary care. A satisfactory cut-off has been identified, which needs validating in general practice. NT pro-BNP could be used to select referrals to a heart failure clinic or for echocardiography. This process needs testing in real-life general practice.

Item Type:Article
Keywords:Diagnoses, Heart failure, Natriuretic peptides.
Full text:Full text not available from this repository.
Publisher Web site:http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1837840&rendertype=abstract
Record Created:30 May 2007
Last Modified:01 Nov 2010 12:26

Social bookmarking: del.icio.usConnoteaBibSonomyCiteULikeFacebookTwitterExport: EndNote, Zotero | BibTex
Usage statisticsLook up in GoogleScholar | Find in a UK Library